United States · 
What does Edwards Lifesciences invest in?
Edwards Lifesciences invests most often at Series A and Series C (50% of the rounds on record), in sectors such as Artificial Intelligence, Medical Device and Biotechnology.
Edwards Lifesciences highlights
- 01
4 rounds on record
- 02
Mostly Series A and Series C: 50% of its rounds
- 03
1 exits from the portfolio
What they do
- Type
- Corporate VC (from a list, unverified)
- Cheque size
- Not stated
- Sectors
- Artificial IntelligenceMedical DeviceBiotechnology
- Based in
- Irvine, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first4 appearances
- 2018
1 round
- Apr
- 2014
1 round
- Dec
- 2013
1 round
- Oct
- 2003
1 round
- Jan
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
We hold 2 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
Exits from the portfolio
Companies it backed that were later bought or listed1 in all
Vascular ArchitectsBought by LeMaitre VascularUndisclosedSept 2007
An exit counts when it came after the firm's first round in the company. From historical deal records.
Companies it bought
Acquisitions by the firm itself
CardiAQ Valve Technologies$350MJul 2015
BMEYEUndisclosedOct 2012
MyocorUndisclosedOct 2008
Percutaneous Valve Technologies (PVT)$125MJan 2004